NCT04422366 2024-06-07
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Shanghai Bovax Biotechnology Co., Ltd.
Phase 3 Recruiting
Shanghai Bovax Biotechnology Co., Ltd.
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC